BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25304611)

  • 1. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
    Manso R; Rodríguez-Pinilla SM; González-Rincón J; Gómez S; Monsalvo S; Llamas P; Rojo F; Pérez-Callejo D; Cereceda L; Limeres MA; Maeso C; Ferrando L; Pérez-Seoane C; Rodríguez G; Arrinda JM; García-Bragado F; Franco R; Rodriguez-Peralto JL; González-Carreró J; Martín-Dávila F; Piris MA; Sánchez-Beato M
    Haematologica; 2015 Jan; 100(1):e25-7. PubMed ID: 25304611
    [No Abstract]   [Full Text] [Related]  

  • 2. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
    Duan R; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral T-cell lymphoma - are we making progress?
    Khan N; Ozkaya N; Moskowitz A; Dogan A; Horwitz S
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):306-314. PubMed ID: 30213401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
    Tensen CP
    J Invest Dermatol; 2015 Sep; 135(9):2153-2154. PubMed ID: 26269406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype.
    de Leval L; Savilo E; Longtine J; Ferry JA; Harris NL
    Am J Surg Pathol; 2001 Mar; 25(3):395-400. PubMed ID: 11224611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intratumoural galectin-1 expression predicts adverse outcome in ALK
    Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
    Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma.
    Shimoyama M; Oyama A; Tajima K; Tobinai K; Minato K; Takenaka T; Konda C; Takeyama K; Kohno A; Narabayashi M
    Leuk Lymphoma; 1993 Jul; 10(4-5):335-42. PubMed ID: 8220132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.
    de Bruin PC; Kummer JA; van der Valk P; van Heerde P; Kluin PM; Willemze R; Ossenkoppele GJ; Radaszkiewicz T; Meijer CJ
    Blood; 1994 Dec; 84(11):3785-91. PubMed ID: 7524749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma.
    Yamashita T; Higashi M; Momose S; Adachi A; Watanabe T; Tanaka Y; Tokuhira M; Kizaki M; Tamaru JI
    Sci Rep; 2020 Jun; 10(1):10391. PubMed ID: 32587329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLCG1 mutations in cutaneous T-cell lymphomas.
    Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM; González-Vela C; Rubio-Camarillo M; Martín-Sánchez E; Pisano DG; Papadavid E; Papadaki T; Requena L; García-Marco JA; Méndez M; Provencio M; Hospital M; Suárez-Massa D; Postigo C; San Segundo D; López-Hoyos M; Ortiz-Romero PL; Piris MA; Sánchez-Beato M
    Blood; 2014 Mar; 123(13):2034-43. PubMed ID: 24497536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru.
    Beltran BE; Morales D; Quinones P; Miranda RN; Goswami M; Castillo JJ
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):196-200. PubMed ID: 21836498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials.
    Ma H; Cheng B; Falchi L; Marchi E; Sawas A; Bhagat G; O'Connor OA
    Hematol Oncol; 2020 Feb; 38(1):51-58. PubMed ID: 31872891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study.
    Toya T; Nannya Y; Hangaishi A; Shiseki M; Shimoyama T; Sakamaki H; Motoji T; Usuki K; Nakamura F; Kurokawa M
    Leuk Lymphoma; 2016; 57(4):961-4. PubMed ID: 26366623
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of survivin expression in peripheral T-cell lymphoma].
    Xiang XJ; He YJ; Li YH; Huang H; Xu F
    Ai Zheng; 2006 Jun; 25(6):758-61. PubMed ID: 16764776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle skin infiltration in hepatosplenic γδ T cell lymphoma.
    Yeung CK; Leung AY; Trendell-Smith NJ; Kwong YL
    Histopathology; 2012 Jul; 61(1):131-2. PubMed ID: 22486414
    [No Abstract]   [Full Text] [Related]  

  • 19. Hodgkin disease associated with T-cell non-Hodgkin lymphomas: case reports and review of the literature.
    Brown JR; Weng AP; Freedman AS
    Am J Clin Pathol; 2004 May; 121(5):701-8. PubMed ID: 15151210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.